Whoa: 2 Indian drug companies report that trials of Merck's molnupiravir found no benefit and will stop. Man is that therapeutic window getting smaller; no good in moderate dz, severe dz, sexually active men & women of childbearing age, ouch. IVM anyone? reuters.com/business/healthc…

1:03 PM · Oct 8, 2021

127
1,665
121
3,572
Replying to @PierreKory
Wow.. Thanks for keeping us informed 🙏🏼
1
0
0
14
Replying to @PierreKory
"There is no significant efficacy against moderate COVID..."
1
0
0
5
Replying to @PierreKory
Bigfarma having a lucrative lend of the world.
0
0
0
7
This Tweet was deleted by the Tweet author.
Yep... our tax dollars at work. Funding Big Pharma
0
0
0
0
Replying to @PierreKory
Clearly they are followers not leaders
0
0
0
1
Replying to @PierreKory
I thought molnupiravir was the 2nd coming of Christ. 1 trial. N=775. But US Govt promises $1 billion +
1
2
0
11
Replying to @PierreKory
I kid you not, we have just been told in med school class that COVID-19 is a viral infection for which there is no reasonable possible intervention in the early stage. EXCEPT maybe Merck's drug. What on earth is going on? Is science becoming selectively blind?
26
30
3
162